Healing & Recovery
Which Tendinopathy Treatments Have the Strongest Evidence?
The short answer
Ranked by evidence quality, progressive loading exercise comes out on top: in a 2026 network meta-analysis of patellar tendinopathy, no other intervention — including blood flow restriction training, flywheel work, or eccentric-only protocols — statistically beat heavy slow resistance training across 10 pooled trials, and a separate network meta-analysis of hip tendinopathy (greater trochanteric pain syndrome) found exercise therapy the single most effective conservative option across 19 trials and 1,701 patients. Corticosteroid injections show real short-term pain relief for tennis elbow but no significant advantage over placebo past 12 weeks. Extracorporeal shockwave therapy fared worst in the newest, most rigorous review: a 2026 meta-analysis of 9 randomized trials found no clinically meaningful benefit over sham for either midportion or insertional Achilles tendinopathy. Platelet-rich plasma's evidence is site-dependent — ranked most likely to help shoulder calcific tendinopathy in one network meta-analysis, but only 'moderate' for tennis elbow in another.
Quick answers
- What is it?
- This ranks common tendinopathy treatments — exercise, corticosteroid injections, shockwave therapy, and PRP — by the quality and consistency of their supporting evidence.
- Why are people interested in it?
- People with tendon pain face many competing treatment options and want to know which ones the strongest studies actually support.
- What has actually been studied?
- Network meta-analyses of patellar tendinopathy (10 trials) and hip tendinopathy (19 trials, 1,701 patients), a Bayesian network meta-analysis of tennis elbow treatments (27 trials), a 2026 shockwave-therapy review (9 trials, 557 patients), and network meta-analyses of PRP for shoulder and elbow tendinopathy.
- How strong is the evidence?
- A consistent pattern across independent reviews of different tendon sites: structured loading exercise performed at or near the top in every network meta-analysis, corticosteroid injections helped only in the short term, and shockwave therapy showed no clinically meaningful benefit over sham in the newest, most rigorous review.
- What don't we know yet?
- Whether any single treatment ranking generalizes across tendon locations, whether early relief from corticosteroids is worth pursuing given the long-term equivalence to placebo, why sham shockwave treatment sometimes outperforms simply waiting, and whether combining treatments outperforms either alone.
- Where can I read the original research?
- Sources at the bottom of this page: Liu Y, Li C, Yang F, BMC Sports Science, Medicine & Rehabilitation, 2026; and Ouyang C, You Q, Yang C, Yu D, Frontiers in Physiology, 2026.
The short answer: Ranked by the quality and consistency of the evidence, loaded exercise programs come out ahead of injections and passive devices. Network meta-analyses in two different tendon locations — the patellar tendon and the hip (greater trochanteric pain syndrome) — both found exercise therapy performed as well as or better than everything it was compared against. Corticosteroid injections work in the short term but that edge disappears by three months. Shockwave therapy, despite being widely marketed, failed to beat a sham treatment in the newest and most rigorous Achilles tendinopathy review. Platelet-rich plasma's evidence is real but narrow — strong for one specific shoulder condition, only moderate for tennis elbow.
What the research shows
Exercise: the most consistent signal, but not a knockout win
A 2026 network meta-analysis of patellar tendinopathy pooled 17 randomized controlled trials, with a primary connected network of 10 studies and 313 participants comparing 11 different exercise-based approaches, using heavy slow resistance (HSR) training as the reference. The result was notable mostly for what didn't happen: no intervention demonstrated statistical superiority over HSR. Eccentric overload training had the most favorable point estimate versus HSR (standardized mean difference 0.33, 95% CI −0.87 to 1.52) but the interval crossed zero by a wide margin, meaning the trials couldn't distinguish it from HSR with any confidence. Flywheel training, eccentric step training, and concentric-only exercise all trended worse than HSR. The authors were explicit that these rankings shouldn't be read as proof of a clinical hierarchy — the evidence network was sparse, and most trials carried some risk of bias, particularly around blinding, which is difficult in any exercise trial.
A separate 2025 network meta-analysis looked at greater trochanteric pain syndrome (hip tendinopathy), pooling 19 randomized trials and 1,701 participants across multiple conservative treatments. Exercise therapy produced the most significant improvement in both pain (measured on a numeric rating scale) and function (VISA-G), with injection therapy showing a secondary advantage specifically on the Harris Hip Scale. Between these two reviews — different tendons, different research groups, different comparison treatments — the throughline is that structured loading exercise consistently performs at or near the top, even when it doesn't statistically dominate every alternative.
Corticosteroid injections: real, but temporary
A 2026 Bayesian network meta-analysis pooled 27 randomized trials on non-surgical treatment of lateral epicondylitis (tennis elbow) and split results by follow-up window. In the short term (roughly 1-4 weeks), corticosteroid injection (CSI) and kinesio taping both produced clinically notable pain reductions versus placebo (mean difference −3.57 and −4.10 respectively, on a 0-10 pain scale). In the intermediate term (4-12 weeks), CSI still outperformed placebo, though by a smaller margin (−1.60). Past 12 weeks, the picture changed entirely: no intervention in the entire network — including CSI — showed a statistically significant advantage over placebo for pain relief. The authors' interpretation was direct: the pain-relieving effects of non-surgical treatments for tennis elbow are time-dependent, and treatment rankings shouldn't be used to make long-term clinical decisions.
Shockwave therapy: the weakest recent evidence, despite wide use
Extracorporeal shockwave therapy (ESWT) is one of the more heavily marketed tendinopathy treatments, but the newest systematic review on it — bluntly subtitled "A Nail in the Coffin?" — pooled 9 randomized controlled trials and 557 patients with Achilles tendinopathy. For insertional Achilles tendinopathy, ESWT showed no clinically meaningful benefit over sham (low-to-moderate certainty evidence), consistent across every outcome and sensitivity analysis run. For midportion Achilles tendinopathy, all analyses (very-low to moderate certainty) found no significant difference in pain or disability between ESWT and control at any follow-up point. One trial did find a benefit over sham but failed to confirm that its blinding actually worked, undermining confidence in that result. The reviewers concluded ESWT should not currently be considered routine treatment for either presentation. A separate 2026 network meta-analysis of ESWT specifically for tennis elbow, pooling 11 randomized trials and 2 cohort studies (938 patients), found that low-energy ESWT had the most favorable overall profile among ESWT variants — but also found that sham ESWT itself significantly outperformed simply waiting for therapy, a result that raises the possibility that some of ESWT's apparent benefit across the literature is a nonspecific or placebo effect rather than a true effect of the shockwaves themselves.
PRP and other injections: promising in some tendons, unremarkable in others
Platelet-rich plasma (PRP) doesn't have one evidence grade across tendinopathy — it varies by anatomical site. A 2025 network meta-analysis of rotator cuff calcific tendinopathy, pooling 19 studies and 1,160 patients, found PRP had the highest probability (85%) of being the most effective conservative option for improving shoulder function, ahead of disodium EDTA injection, needle aspiration, and ESWT. But a 2026 network meta-analysis focused specifically on tennis elbow, comparing physical and minimally invasive interventions across 38 randomized trials, found PRP and corticosteroid injections both showed only "moderate effectiveness" — well behind percutaneous electrolysis for short-term pain relief and dry needling for functional recovery in that dataset. The takeaway is that PRP's evidence doesn't transfer cleanly from one tendon to another, and claims about it should be evaluated site by site.
What we don't know yet
Whether any single ranking generalizes across tendon locations. The reviews retrieved here studied the patellar tendon, Achilles tendon, hip, elbow, and shoulder separately, using different comparator treatments and outcome measures — there is no head-to-head network spanning all tendon sites at once.
Whether early relief from corticosteroids is worth pursuing given the long-term equivalence to placebo. The tennis elbow network meta-analysis found real short-term benefit and no long-term benefit from the same injection, but did not assess whether that short-term relief changes the overall course of recovery.
Why sham shockwave treatment sometimes outperforms simply waiting. The tennis elbow ESWT network meta-analysis found this pattern directly, and it complicates interpretation of every ESWT trial that doesn't include a genuine no-treatment or wait-list arm alongside the sham arm.
Long-term (beyond roughly 12 months) comparative data for most of these treatments. Nearly every review here was limited to follow-up windows of a few months; almost none reported outcomes a year or more out.
Whether combining treatments (for example, exercise plus PRP, or exercise plus corticosteroid) outperforms either alone. Most of the network meta-analyses compared single interventions; combination protocols were underrepresented or excluded from the connected evidence networks.
Sources
- Liu Y, Li C, Yang F. Comparative effectiveness of exercise interventions for patellar tendinopathy: a systematic review and network meta-analysis of randomized controlled trials. BMC Sports Science, Medicine & Rehabilitation, 2026;18(1). DOI
- Ouyang C, You Q, Yang C, Yu D. Time-dependent comparative efficacy of non-surgical treatments for pain relief in lateral epicondylitis: a systematic review and network meta-analysis. Frontiers in Physiology, 2026;17:1782562. DOI
- Korakakis V, Kotsifaki R, Sotiralis Y, Malliaras P. Shockwave Therapy for Midportion and Insertional Achilles Tendinopathy: A Nail in the Coffin? A Systematic Review With Meta-Analysis. Journal of Orthopaedic and Sports Physical Therapy, 2026;56(5):282-299. DOI
- Wang SQ, Guo NY, Liu W, Huang HJ, Xu BB, Wang JQ. Effect of conservative treatment on greater trochanteric pain syndrome: a systematic review and network meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research, 2025;20(1):126. DOI
- Moggio L, Marotta N, de Sire A, Benedetto GL, Gasparini G, Ammendolia A, Parrotta EI, Mercurio M. Efficacy of Conservative Approaches on Pain Relief and Function in Patients With Rotator Cuff Calcific Tendinopathy: A Systematic Review and Network Meta-Analysis. Orthopaedic Surgery, 2025;17(11):3048-3066. DOI
- Song YH, Lan JY, Fu HH, Tang LX. Short-term efficacy of physical interventions for lateral epicondylitis: a network meta-analysis based on multidimensional evaluation of pain and function. Frontiers in Pain Research, 2026;7:1855508. DOI
- Jin R, Wang H, Lv W, Cheng H, Li Y, Yuan Q. Comparison of the efficacy of different types and intensities of extracorporeal shock wave therapy for lateral epicondylitis: a systematic review and network meta-analysis. Journal of Orthopaedic Surgery and Research, 2026;21(1). DOI
Article records maintained via PubMed. Peptide Proof reports what studies found. It does not provide medical advice, dosing guidance, or treatment recommendations.
Topic: Recovery & Tissue Research
Sources
- Comparative effectiveness of exercise interventions for patellar tendinopathy: a systematic review and network meta-analysis of randomized controlled trials
- BMC Sports Science, Medicine & Rehabilitation, 2026 · n=313 · DOI
- Time-dependent comparative efficacy of non-surgical treatments for pain relief in lateral epicondylitis: a systematic review and network meta-analysis
- Frontiers in Physiology, 2026 · n=27 · DOI
- Shockwave Therapy for Midportion and Insertional Achilles Tendinopathy: A Nail in the Coffin? A Systematic Review With Meta-Analysis
- Journal of Orthopaedic and Sports Physical Therapy, 2026 · n=557 · DOI
- Effect of conservative treatment on greater trochanteric pain syndrome: a systematic review and network meta-analysis of randomized controlled trials
- Journal of Orthopaedic Surgery and Research, 2025 · n=1701 · DOI
- Efficacy of Conservative Approaches on Pain Relief and Function in Patients With Rotator Cuff Calcific Tendinopathy: A Systematic Review and Network Meta-Analysis
- Orthopaedic Surgery, 2025 · n=1160 · DOI
- Short-term efficacy of physical interventions for lateral epicondylitis: a network meta-analysis based on multidimensional evaluation of pain and function
- Frontiers in Pain Research, 2026 · DOI
- Comparison of the efficacy of different types and intensities of extracorporeal shock wave therapy for lateral epicondylitis: a systematic review and network meta-analysis
- Journal of Orthopaedic Surgery and Research, 2026 · n=938 · DOI
Get the evidence, not the hype.
New research briefs, plainly written and fully sourced. No dosing advice, ever.